Faculty home

Pharmacy and Pharmaceutical Sciences

Only through community and collaboration can we achieve the best possible results. Together we aim to shift gears and change old ways of thinking. And we need people like you – your skills, your perspectives, your passion.

Stay up-to-date with the latest news from inside the world of Pharmacy and Pharmaceutical Sciences.

Faculty celebrates 25 years as part of Monash University

Monash Pharmacy and Pharmaceutical Sciences today celebrated the 25th anniversary of the amalgamation between Monash University and the faculty’s predecessor institution, the Victorian College of Pharmacy.

MIPS and Starpharma awarded STEM+ Business Fellowships to further targeted delivery technologies for cancer

The ARC Centre of Excellence in Convergent Bio-Nano Science and Technology (CBNS) at the Monash Institute of Pharmaceutical Sciences (MIPS) and biotechnology company Starpharma have been awarded two grants from the Federal Government’s Science and Industry Endowment Fund STEM+ Business Fellowship Program to further their work in targeted delivery approaches to cancer. SIEF and Starpharma will together fund $601,712 to further advance programs utilising Starpharma’s DEP® drug delivery platform.

Monash research sparks major change in editorial policy

Monash University drug discovery research has led to a change in editorial policy of the world’s largest scientific society, in a move that could save government and industry millions of dollars a year in preventing dead-end research.

Bob Blouin, Dean of Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, receives honorary degree from Monash University

In a graduation ceremony earlier today, Monash University has conferred an honorary doctorate upon Professor Robert A. “Bob” Blouin, Dean of the UNC Eshelman School of Pharmacy at the University of North Carolina (UNC) at Chapel Hill.

Meri Canals in DDB Laboritory

MIPS researchers find piece in inflammatory disease puzzle

Inflammation is part of the body’s natural healing process, but when it gets out of control it can cause disease. Monash Institute of Pharmaceutical Sciences (MIPS) researchers, in collaboration with researchers from the Monash Biomedicine Discovery Institute (BDI) have shed light on a key aspect of this process. Their findings may help guide the development of new treatments of inflammatory diseases such as atherosclerosis, which can lead to heart attack or stroke, and type 2 diabetes.

View more articles